Victory Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.5M | Buy |
760,252
+134,948
| +22% | +$4.61M | 0.02% | 795 |
|
|
2026
Q1 | $20.7M | Buy |
625,304
+168,009
| +37% | +$7.11M | 0.01% | 864 |
|
|
2025
Q4 | $21.2M | Sell |
457,295
-22,377
| -5% | -$936K | 0.01% | 854 |
|
|
2025
Q3 | $16.8M | Sell |
479,672
-29,084
| -6% | -$1.01M | 0.01% | 937 |
|
|
2025
Q2 | $15M | Buy |
508,756
+10,043
| +2% | +$286K | 0.01% | 977 |
|
|
2025
Q1 | $14.9M | Sell |
498,713
-60,823
| -11% | -$1.86M | 0.02% | 912 |
|
|
2024
Q4 | $16M | Sell |
559,536
-151,152
| -21% | -$5M | 0.02% | 931 |
|
|
2024
Q3 | $27.5M | Buy |
710,688
+215,874
| +44% | +$7.7M | 0.03% | 713 |
|
|
2024
Q2 | $15.9M | Sell |
494,814
-31,149
| -6% | -$1.08M | 0.02% | 897 |
|
|
2024
Q1 | $20.4M | Sell |
525,963
-197,334
| -27% | -$6.9M | 0.02% | 810 |
|
|
2023
Q4 | $22.3M | Sell |
723,297
-24,974
| -3% | -$626K | 0.02% | 738 |
|
|
2023
Q3 | $16.7M | Sell |
748,271
-29,826
| -4% | -$680K | 0.02% | 813 |
|
|
2023
Q2 | $16.7M | Buy |
778,097
+681,814
| +708% | +$15.5M | 0.02% | 841 |
|
|
2023
Q1 | $2.31M | Sell |
96,283
-13,314
| -12% | -$353K | ﹤0.01% | 1360 |
|
|
2022
Q4 | $2.54M | Sell |
109,597
-18,309
| -14% | -$369K | ﹤0.01% | 1360 |
|
|
2022
Q3 | $2.05M | Sell |
127,906
-4,794
| -4% | -$84.5K | ﹤0.01% | 1438 |
|
|
2022
Q2 | $2.35M | Buy |
132,700
+23,169
| +21% | +$390K | ﹤0.01% | 1421 |
|
|
2022
Q1 | $1.95M | Sell |
109,531
-2,389
| -2% | -$45.1K | ﹤0.01% | 1504 |
|
|
2021
Q4 | $2.09M | Hold |
111,920
| – | – | ﹤0.01% | 1536 |
|
|
2021
Q3 | $2.21M | Buy |
111,920
+10,036
| +10% | +$217K | ﹤0.01% | 1568 |
|
|
2021
Q2 | $2.41M | Buy |
101,884
+44,179
| +77% | +$1.02M | ﹤0.01% | 1576 |
|
|
2021
Q1 | $1.37M | Buy |
57,705
+6,527
| +13% | +$155K | ﹤0.01% | 1761 |
|
|
2020
Q4 | $1.02M | Buy |
51,178
+2,661
| +5% | +$52K | ﹤0.01% | 1775 |
|
|
2020
Q3 | $1.01M | Sell |
48,517
-8,282
| -15% | -$149K | ﹤0.01% | 1700 |
|
|
2020
Q2 | $994K | Buy |
56,799
+7,940
| +16% | +$155K | ﹤0.01% | 1738 |
|
|
2020
Q1 | $798K | Buy |
48,859
+10,072
| +26% | +$208K | ﹤0.01% | 1675 |
|
|
2019
Q4 | $798K | Sell |
38,787
-4,449
| -10% | -$74.2K | ﹤0.01% | 1813 |
|
|
2019
Q3 | $496K | Buy |
43,236
+42,049
| +3,542% | +$480K | ﹤0.01% | 1886 |
|
|
2019
Q2 | $16K | Hold |
1,187
| – | – | ﹤0.01% | 1797 |
|
|
2019
Q1 | $18K | Hold |
1,187
| – | – | ﹤0.01% | 1747 |
|
|
2018
Q4 | $20K | Sell |
1,187
-226
| -16% | -$3.87K | ﹤0.01% | 1740 |
|
|
2018
Q3 | $21K | Buy |
1,413
+186
| +15% | +$3.3K | ﹤0.01% | 1756 |
|
|
2018
Q2 | $29K | Buy |
+1,227
| New | +$30.2K | ﹤0.01% | 1779 |
|
Other funds holding COLL
JT
EAM
Victory Capital Management's COLL Position: Q2 2026 in Review
Victory Capital Management increased its Collegium Pharmaceutical (COLL) stake by 22% in Q2 2026, buying an estimated $4.61M and bringing the position to 760,252 shares worth $27.5M. The position accounts for 0.02% of the portfolio, ranked #795.
Victory Capital Management first reported a position in COLL in Q2 2018 and has held it in 33 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.
- Victory Capital Management held 760,252 shares of Collegium Pharmaceutical worth $27.5M as of Q2 2026.
- Victory Capital Management bought 134,948 Collegium Pharmaceutical shares in Q2 2026, an estimated $4.61M.
- Collegium Pharmaceutical made up 0.02% of Victory Capital Management's portfolio in Q2 2026, its #795 holding.
- Victory Capital Management first reported a position in Collegium Pharmaceutical in Q2 2018 and has held it in 33 quarters since.
- 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.